Arix Bioscience plc (ARIX.L) LSE

142.00

-1.5(-1.05%)

Updated at February 09, 2024 05:15PM

Currency In GBp

Valuation

Market Cap142.29M
Enterprise Value19.58M
P/E Ratio-6.82
PEG Ratio-0.07
Price/Sales Ratio1,640.48
Price/Book Ratio0.83
Enterprise/Revenue544.84
Enterprise/EBITDA2.37

Fiscal Year

Fiscal YearDecember 31, 2022
Most Recent QuarterJune 30, 2023

Profitability

Profit Margin-246.21
Operating Margin227.46

Management Effectiveness

Return On Assets-0.12
Return On Equity-0.11

Income Statement

Revenue112,000
Revenue/Share0
Gross Profit112,000
EBITDA25.7M
Net Income-27.58M
Diluted EPS-0.21

Balance Sheet

Total Cash100.99M
Total Cash/Share0.93
Total Debt37,000
Total Debt/Equity0
Current Ratio65
Book Value Per Share1.71

Price History

52-Week Change19.83
52-Week High145
52-Week Low142
Moving Average 50 Days129.4
Moving Average 200 Days115.93

Statistics

Average Volume462,154
Shares Outstanding129.39M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A